Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.68
ESMC's Cash-to-Debt is ranked lower than
69% of the 325 Companies
in the Global Medical Devices industry.

( Industry Median: 2.55 vs. ESMC: 0.68 )
Ranked among companies with meaningful Cash-to-Debt only.
ESMC' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 7.44 Max: No Debt
Current: 0.68
Equity-to-Asset 0.26
ESMC's Equity-to-Asset is ranked lower than
88% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 0.63 vs. ESMC: 0.26 )
Ranked among companies with meaningful Equity-to-Asset only.
ESMC' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.02  Med: 0.64 Max: 0.97
Current: 0.26
0.02
0.97
Piotroski F-Score: 2
Altman Z-Score: -15.33
Beneish M-Score: -2.34
WACC vs ROIC
3.04%
-61.03%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 2/10

vs
industry
vs
history
Operating Margin % -8.94
ESMC's Operating Margin % is ranked lower than
63% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 2.62 vs. ESMC: -8.94 )
Ranked among companies with meaningful Operating Margin % only.
ESMC' s Operating Margin % Range Over the Past 10 Years
Min: -50.06  Med: -10.71 Max: 14.93
Current: -8.94
-50.06
14.93
Net Margin % -9.33
ESMC's Net Margin % is ranked lower than
61% of the 304 Companies
in the Global Medical Devices industry.

( Industry Median: 1.55 vs. ESMC: -9.33 )
Ranked among companies with meaningful Net Margin % only.
ESMC' s Net Margin % Range Over the Past 10 Years
Min: -51.87  Med: -7.04 Max: 22.82
Current: -9.33
-51.87
22.82
ROE % -54.26
ESMC's ROE % is ranked lower than
80% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 1.31 vs. ESMC: -54.26 )
Ranked among companies with meaningful ROE % only.
ESMC' s ROE % Range Over the Past 10 Years
Min: -173.96  Med: -31.89 Max: 117.3
Current: -54.26
-173.96
117.3
ROA % -19.09
ESMC's ROA % is ranked lower than
66% of the 327 Companies
in the Global Medical Devices industry.

( Industry Median: 0.06 vs. ESMC: -19.09 )
Ranked among companies with meaningful ROA % only.
ESMC' s ROA % Range Over the Past 10 Years
Min: -45.53  Med: -13.35 Max: 30.83
Current: -19.09
-45.53
30.83
ROC (Joel Greenblatt) % -59.85
ESMC's ROC (Joel Greenblatt) % is ranked lower than
64% of the 323 Companies
in the Global Medical Devices industry.

( Industry Median: 4.26 vs. ESMC: -59.85 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
ESMC' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -167.54  Med: -56.21 Max: 67.46
Current: -59.85
-167.54
67.46
3-Year Revenue Growth Rate 0.20
ESMC's 3-Year Revenue Growth Rate is ranked lower than
67% of the 237 Companies
in the Global Medical Devices industry.

( Industry Median: 4.40 vs. ESMC: 0.20 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
ESMC' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -68.2  Med: 1.9 Max: 179.4
Current: 0.2
-68.2
179.4
3-Year EBITDA Growth Rate -0.70
ESMC's 3-Year EBITDA Growth Rate is ranked lower than
61% of the 208 Companies
in the Global Medical Devices industry.

( Industry Median: 5.10 vs. ESMC: -0.70 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
ESMC' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -57  Med: -14 Max: 94.6
Current: -0.7
-57
94.6
3-Year EPS without NRI Growth Rate -2.10
ESMC's 3-Year EPS without NRI Growth Rate is ranked lower than
54% of the 203 Companies
in the Global Medical Devices industry.

( Industry Median: 1.40 vs. ESMC: -2.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
ESMC' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -76.2  Med: -29.2 Max: 80.1
Current: -2.1
-76.2
80.1
GuruFocus has detected 3 Warning Signs with Escalon Medical Corp $ESMC.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» ESMC's 10-Y Financials

Financials (Next Earnings Date: 2017-05-16 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with ESMC

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Medical Devices » Medical Devices    NAICS: 334510    SIC: 3845
Compare:OTCPK:ACXA, OTCPK:BIAD, OTCBB:GTHP, OTCPK:EQUR, OTCPK:ACAR, NAS:SSH, OTCPK:PETV, OTCPK:VYCO, OTCPK:MPHMF, OTCPK:AIRW, OTCPK:IGNG, AMEX:NSPR, NAS:PHMD, NAS:MDGS, NAS:AHPI, OTCPK:PYNGF, OTCPK:NUMD, AMEX:XTNT, OTCPK:PBIO, NAS:EVAR » details
Traded in other countries:ES4.Germany,
Headquarter Location:USA
Escalon Medical Corp operates in the healthcare market. The Company is engaged in the development, manufacture, marketing and distribution of medical devices for use in ophthalmology.

Escalon Medical Corp. ( 'Escalon') is a Pennsylvania corporation initially incorporated in California in 1987 and reincorporated in Pennsylvania in November 2001. The Company operates in the healthcare market specializing in the development, manufacture, marketing and distribution of medical devices and pharmaceuticals in the areas of ophthalmology, diabetes, hematology and vascular access. Drew is a diagnostics Company specializing in the design, manufacture and distribution of instruments for blood cell counting and blood analysis. Drew is focused on providing instrumentation and consumables for the physician office and veterinary office laboratories. Drew sells two diabetic testing products: the DS5 and the Hb-Gold. The DS5 instrument, dispenser and associated reagent kit measure long-term glucose control in diabetic patients. Drew offers a array of equipment for use in the field of human and veterinary hematology. Sonomed develops, manufactures and markets ultrasound systems for diagnostic or biometric applications in ophthalmology. The systems are of four types: A-Scans, B-Scans, High Frequency B-Scans ( 'UBMs') and pachymeters. The A-Scan provides information about the internal structure of the eye by sending a beam of ultrasound along a fixed axis through the eye and displaying the various echoes reflected from the surfaces intersected by the beam. The B-Scan is a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque. The UBM is a high frequency/high resolution ultrasound device, designed to provide highly detailed information of the anterior segment of the eye. The pachymeter uses the same principles as the A-Scan, but the system is tailored to measure the thickness of the cornea. The Company distributes two intraocular gas products C3F8 and SF6, which are used by vitreoretinal surgeons as a temporary tamponade in detached retina surgery. The Company conducts development of medical devices for the diagnosis and monitoring of medical disorders in the areas of diabetes, cardiovascular diseases and hematology at the Company's Dallas, Texas, Miami, Florida and Rennes, France facilities. The Company conducts medical device and vascular access product development at its New Berlin, Wisconsin facility. The Company has 13 United States patents and 28 patents issued abroad that cover the Company's surgical products and pharmaceutical technology. The Company's competitors include ophthalmic-oriented companies that market a broad portfolio of products, including prescription ophthalmic pharmaceuticals, ophthalmic devices, consumer products and other eye care products; large integrated pharmaceutical companies that market a limited number of ophthalmic pharmaceuticals in addition to many other pharmaceuticals; and smaller specialty pharmaceutical and biotechnology companies. The Company's products are subject to stringent ongoing regulation by the FDA and similar health authoritie

Ratios

vs
industry
vs
history
PB Ratio 0.83
ESMC's PB Ratio is ranked higher than
97% of the 298 Companies
in the Global Medical Devices industry.

( Industry Median: 3.11 vs. ESMC: 0.83 )
Ranked among companies with meaningful PB Ratio only.
ESMC' s PB Ratio Range Over the Past 10 Years
Min: 0.3  Med: 1.42 Max: 46.82
Current: 0.83
0.3
46.82
PS Ratio 0.11
ESMC's PS Ratio is ranked higher than
99% of the 296 Companies
in the Global Medical Devices industry.

( Industry Median: 3.20 vs. ESMC: 0.11 )
Ranked among companies with meaningful PS Ratio only.
ESMC' s PS Ratio Range Over the Past 10 Years
Min: 0.06  Med: 0.57 Max: 1.4
Current: 0.11
0.06
1.4
EV-to-EBIT -1.45
ESMC's EV-to-EBIT is ranked lower than
99.99% of the 275 Companies
in the Global Medical Devices industry.

( Industry Median: 24.54 vs. ESMC: -1.45 )
Ranked among companies with meaningful EV-to-EBIT only.
ESMC' s EV-to-EBIT Range Over the Past 10 Years
Min: -32.3  Med: -3.7 Max: 0.5
Current: -1.45
-32.3
0.5
EV-to-EBITDA -1.50
ESMC's EV-to-EBITDA is ranked lower than
99.99% of the 300 Companies
in the Global Medical Devices industry.

( Industry Median: 19.31 vs. ESMC: -1.50 )
Ranked among companies with meaningful EV-to-EBITDA only.
ESMC' s EV-to-EBITDA Range Over the Past 10 Years
Min: -33.4  Med: -4.8 Max: 0.5
Current: -1.5
-33.4
0.5
Current Ratio 1.40
ESMC's Current Ratio is ranked lower than
80% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 2.38 vs. ESMC: 1.40 )
Ranked among companies with meaningful Current Ratio only.
ESMC' s Current Ratio Range Over the Past 10 Years
Min: 0.51  Med: 2.77 Max: 27.33
Current: 1.4
0.51
27.33
Quick Ratio 0.72
ESMC's Quick Ratio is ranked lower than
88% of the 321 Companies
in the Global Medical Devices industry.

( Industry Median: 1.79 vs. ESMC: 0.72 )
Ranked among companies with meaningful Quick Ratio only.
ESMC' s Quick Ratio Range Over the Past 10 Years
Min: 0.27  Med: 1.56 Max: 24.67
Current: 0.72
0.27
24.67
Days Inventory 138.67
ESMC's Days Inventory is ranked lower than
53% of the 289 Companies
in the Global Medical Devices industry.

( Industry Median: 130.04 vs. ESMC: 138.67 )
Ranked among companies with meaningful Days Inventory only.
ESMC' s Days Inventory Range Over the Past 10 Years
Min: 101.62  Med: 155.23 Max: 204.55
Current: 138.67
101.62
204.55
Days Sales Outstanding 48.35
ESMC's Days Sales Outstanding is ranked higher than
79% of the 272 Companies
in the Global Medical Devices industry.

( Industry Median: 68.94 vs. ESMC: 48.35 )
Ranked among companies with meaningful Days Sales Outstanding only.
ESMC' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.8  Med: 50.43 Max: 57.65
Current: 48.35
42.8
57.65
Days Payable 71.81
ESMC's Days Payable is ranked higher than
57% of the 259 Companies
in the Global Medical Devices industry.

( Industry Median: 59.71 vs. ESMC: 71.81 )
Ranked among companies with meaningful Days Payable only.
ESMC' s Days Payable Range Over the Past 10 Years
Min: 32.18  Med: 46.66 Max: 86.2
Current: 71.81
32.18
86.2

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -0.10
ESMC's 3-Year Average Share Buyback Ratio is ranked higher than
83% of the 218 Companies
in the Global Medical Devices industry.

( Industry Median: -3.90 vs. ESMC: -0.10 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
ESMC' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -71.7  Med: -5.4 Max: 0
Current: -0.1
-71.7
0

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 2.66
ESMC's Price-to-Net-Current-Asset-Value is ranked higher than
95% of the 206 Companies
in the Global Medical Devices industry.

( Industry Median: 6.88 vs. ESMC: 2.66 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
ESMC' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 0.83  Med: 2.99 Max: 33.33
Current: 2.66
0.83
33.33
Price-to-Tangible-Book 2.19
ESMC's Price-to-Tangible-Book is ranked higher than
88% of the 263 Companies
in the Global Medical Devices industry.

( Industry Median: 4.11 vs. ESMC: 2.19 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
ESMC' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.61  Med: 2.57 Max: 126.25
Current: 2.19
0.61
126.25
Price-to-Median-PS-Value 0.19
ESMC's Price-to-Median-PS-Value is ranked higher than
96% of the 242 Companies
in the Global Medical Devices industry.

( Industry Median: 1.03 vs. ESMC: 0.19 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
ESMC' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.13  Med: 1.43 Max: 90.63
Current: 0.19
0.13
90.63
Earnings Yield (Greenblatt) % -68.97
ESMC's Earnings Yield (Greenblatt) % is ranked lower than
91% of the 432 Companies
in the Global Medical Devices industry.

( Industry Median: 2.17 vs. ESMC: -68.97 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
ESMC' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -68.97  Med: 483.5 Max: 677.7
Current: -68.97
-68.97
677.7
Forward Rate of Return (Yacktman) % 126.77
ESMC's Forward Rate of Return (Yacktman) % is ranked higher than
99% of the 125 Companies
in the Global Medical Devices industry.

( Industry Median: 8.85 vs. ESMC: 126.77 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
ESMC' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -67.7  Med: -7.1 Max: 126.77
Current: 126.77
-67.7
126.77

More Statistics

Revenue (TTM) (Mil) $11.30
EPS (TTM) $ -0.14
Beta0.03
Short Percentage of Float0.03%
52-Week Range $0.07 - 1.29
Shares Outstanding (Mil)7.55

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)